Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 5INDUSTRY 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 35Prostatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 24Lung Neoplasms 15Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Carcinoma, Ovarian Epithelial 7Adenocarcinoma of Lung 7Inflammatory Breast Neoplasms 6Fallopian Tube Neoplasms 6Breast Neoplasms, Male 6Stomach Neoplasms 4Head and Neck Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Tongue Neoplasms 3Pain 3Neoplasm Metastasis 3Adenocarcinoma, Bronchiolo-Alveolar 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Pleural Effusion, Malignant 2Oropharyngeal Neoplasms 2Neoplasms 2Lymphoid Interstitial Pneumonia 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Brenner Tumor 2

Interventions

Radiotherapy 4Cisplatin 4Paclitaxel 3Gemcitabine 3Fluorouracil 3Oxaliplatin 2fluoromisonidazole 1dl1520 1Semaxinib 1Rubidium-82 1Ritonavir 1Nivolumab 1Nicotine 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Indinavir 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Filgrastim 1Endoscopic Mucosal Resection 1EBV-associated membrane antigen, Epstein-Barr virus 1Docetaxel 1Bronchoscopy 1Bortezomib 1Amifostine 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Nasopharyngeal Neoplasms × Docetaxel × Clear all
NCT00004164 2009-02-09

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

National Cancer Institute (NCI)

Phase 2 Unknown
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡